SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-19-021637
Filing Date
2019-10-31
Accepted
2019-10-31 16:20:53
Documents
2
Group Members
ALPHA BIOLABS, INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13D sc13d1019a5alpha_oncosec.htm SC 13D/A 62943
2 PRESS RELEASE DATED OCTOBER 30, 2019 sc13d1019a5ex99-1alpha_onco.htm EX-99.1 20155
  Complete submission text file 0001213900-19-021637.txt   84632
Mailing Address 24 N. MAIN STREET PENNINGTON NJ 08534
Business Address 24 N. MAIN STREET PENNINGTON NJ 08534 (858) 210-7333
ONCOSEC MEDICAL Inc (Subject) CIK: 0001444307 (see all company filings)

IRS No.: 980573252 | State of Incorp.: NV | Fiscal Year End: 0731
Type: SC 13D/A | Act: 34 | File No.: 005-86770 | Film No.: 191183890
SIC: 2834 Pharmaceutical Preparations

Mailing Address GANGNAM-GU APGUJEONG-RO 62-GIL 17-10 SEOUL M5 06016
Business Address GANGNAM-GU APGUJEONG-RO 62-GIL 17-10 SEOUL M5 06016 011-8225178841
Alpha Holdings, Inc. (Filed by) CIK: 0001755469 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A